What should I monitor with domperidone?

If you experience any symptoms such as dizziness, fainting or heart palpitations while you are taking domperidone, you should stop taking this medicine and seek medical attention. These symptoms may be due to an abnormal heart rhythm caused by domperidone.

What are the contraindications of domperidone?

Domperidone is now contraindicated in people:

  • with conditions where cardiac conduction is, or could be, impaired.
  • with underlying cardiac diseases such as congestive heart failure.
  • receiving other medications known to prolong QT interval or potent CYP3A4 inhibitors.
  • with severe hepatic impairment.

What drugs does domperidone interact with?

Drug Interactions

  • Bepridil.
  • Cisapride.
  • Darunavir.
  • Dronedarone.
  • Fluconazole.
  • Ketoconazole.
  • Levoketoconazole.
  • Mesoridazine.

Does domperidone increase blood pressure?

Conclusion: Domperidone increases blood pressure and heart rate without inducing nocturnal hypertension in apomorphine treated patients with idiopathic Parkinson’s disease. Increased heart rate by domperidone is a new finding but the clinical significance is unclear and requires further investigation.

Does domperidone raise blood pressure?

What is the difference between domperidone and domperidone Maleate?

A dopamine antagonist, domperidone is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The maleate salt is used in tablet preparations, while the free base is used in oral suspensions.

What is domperidone Maleate used for?

About domperidone Domperidone is an anti-sickness medicine. It helps you to stop feeling or being sick (nausea or vomiting). It can also be used to treat stomach pain if you’re having end of life care (palliative care).

What is domperidone Maleate?

Is domperidone contraindicated in hypertension?

Does domperidone cause low blood sugar?

The infusion of 5 micrograms/kg/min of domperidone increased significantly plasma insulin levels during the acute phase of glucose-induced insulin release and lowered plasma glucose values at 50 and 60 min; the k of glucose disappearance improved significantly.